BetterLife Pharma files for public offering of common shares, pre-funded warrants

PUBT · 3d ago
BetterLife Pharma files for public offering of common shares, pre-funded warrants
  • BetterLife Pharma filed a preliminary short-form prospectus for an offering of common shares or pre-funded warrants.
  • Bloom Burton Securities, Haywood Securities to act as agents on a commercially reasonable efforts basis.
  • Deal size, security mix, pricing to be set at launch following negotiations with the agents.
  • Proceeds earmarked for Phase 1A studies, parallel Phase 1B trials, Phase 2 trials, working capital.
  • Closing targeted on or about Sept. 15, 2026, subject to definitive documentation and regulatory, exchange approvals.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BetterLife Pharma Inc. published the original content used to generate this news brief on August 24, 2026, and is solely responsible for the information contained therein.